Maia Strategy provides its Diagnostics clients with the insights required to grow and defend market share, in an industry that has grown increasingly more sophisticated and highly-regulated.   Leading diagnostics companies turn to Maia Strategy when evaluating geographic expansion strategies, M&A opportunities, and product rationalization initiatives.

Maia helps its clients to develop winning strategies for the following markets and product areas:

  • Point-of-Care Testing (POCT)
  • In-Vitro Laboratory Based Testing (both clinical and academic)
  • Reference Laboratories
  • NIPT
  • Sequencing
  • Digital Pathology

Our primary research provide clients with insights from hard-to-reach decision-makers, including care providers and lab directors at Centers of Excellence, government regulatory staff, clinical trial personnel, and academic researchers.